Zhonghua Wai Ke Za Zhi. 2023 Aug 1;61(8):617-644. doi: 10.3760/cma.j.cn112139-20230603-00222.
Colorectal cancer is one of the most common malignant tumors in China. In recent years, the incidence and mortality of colorectal cancer in China has been on the rise. According to the China Cancer Statistics Report in 2020, the incidence and mortality of colorectal cancer in China ranked second and fifth among all malignant tumors, with 555, 000 new cases and 286, 000 deaths. China has become the country with the highest number of new cases and deaths of colorectal cancer every year in the world, which seriously threatens the health of Chinese residents. In 2010, the National Ministry of Health organized the colorectal cancer expertise of the Chinese Medical Association to write the Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2010 edition) and publish it publicly. Since 2010, the National Health and Family Planning Commission has organized experts to revise the protocol in 2015 and 2017, while the National Health Commission revised it in 2020 and 2023. The revised part of the Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2023 edition) involves new progress in the field of imaging examination, pathological evaluation, surgery, chemotherapy and radiotherapy. The 2023 edition of the protocol not only referred to the contents of the international guidelines, but also combined with specific national conditions and clinical practice in China, and also included many evidence-based clinical data recently in China. The 2023 edition of the protocol would further promote the standardization of the diagnosis and treatment of colorectal cancer in China, improve the survival and prognosis of patients, and benefit millions of patients with colorectal cancer and their families.
结直肠癌是中国最常见的恶性肿瘤之一。近年来，中国结直肠癌的发病率和死亡率呈上升趋势。根据《2020年中国癌症统计报告》，中国结直肠癌的发病率和死亡率在所有恶性肿瘤中分别位居第二和第五，新发病例55.5万例，死亡28.6万例。中国已成为全球每年结直肠癌新发病例和死亡人数最多的国家，严重威胁中国居民健康。2010年，国家卫生部组织中华医学会结直肠癌专业专家编写了《中国结直肠癌诊疗规范（2010年版）》并公开发布。自2010年起，国家卫生和计划生育委员会于2015年和2017年组织专家对该规范进行修订，国家卫生健康委员会于2020年和2023年进行修订。《中国结直肠癌诊疗规范（2023年版）》修订部分涉及影像检查、病理评估、手术、化疗及放疗等领域的新进展。2023年版规范不仅参考了国际指南的内容，还结合了中国具体国情和临床实际，纳入了国内近期多项循证医学临床资料。2023年版规范将进一步推动中国结直肠癌诊疗的规范化，提高患者生存率和预后，惠及数百万结直肠癌患者及其家庭。
